S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
S&P 500   4,975.51 (-0.60%)
DOW   38,563.80 (-0.17%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.91 (-0.35%)
F   12.25 (-0.41%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.59 (-0.11%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)

Avenue Therapeutics (ATXI) SEC Filings & 10K Form

$0.15
0.00 (0.00%)
(As of 02/20/2024 ET)

Recent Avenue Therapeutics SEC Filings

DateFilerForm TypeView
02/01/2024
11:15 PM
Avenue Therapeutics (Filer)
Form EFFECT
01/29/2024
7:00 AM
Avenue Therapeutics (Filer)
Form DEF 14C
01/17/2024
4:05 PM
Avenue Therapeutics (Filer)
Form PRE 14C
01/12/2024
5:01 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:28 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
2:45 PM
Avenue Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
11/28/2023
3:01 PM
Avenue Therapeutics (Issuer)
Davidow Robert L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/24/2023
12:19 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:10 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
8:00 AM
Avenue Therapeutics (Filer)
Form 424B4
10/31/2023
11:15 PM
Avenue Therapeutics (Filer)
Form EFFECT
10/23/2023
7:50 PM
Avenue Therapeutics (Filer)
Form S-1/A
10/05/2023
4:05 PM
Avenue Therapeutics (Subject)
Form FWP
09/29/2023
4:23 PM
Avenue Therapeutics (Filer)
Form S-1/A
09/28/2023
3:25 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
4:08 PM
Avenue Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
Form SC 13D/A
09/18/2023
4:18 PM
Avenue Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/12/2023
8:02 AM
Avenue Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
8:03 AM
Avenue Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
3:37 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
12:05 PM
Avenue Therapeutics (Issuer)
MacLean Alexandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
11:15 PM
Avenue Therapeutics (Filer)
Form EFFECT
06/26/2023
3:15 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
3:31 PM
Avenue Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/12/2023
3:15 PM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2023
7:35 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2023
3:30 PM
Avenue Therapeutics (Filer)
Form 424B3
05/03/2023
11:15 PM
Avenue Therapeutics (Filer)
Form EFFECT
03/30/2023
3:07 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2023
7:05 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ATXI) was last updated on 2/20/2024 by MarketBeat.com Staff